A useful model to study the effect of high sugar concentrations upon growth and enzymic activities of toad embryos and larvae

Comparative Biochemistry and Physiology - C Pharmacology Toxicology and Endocrinology

Volumn 126, Issue 3, 2000, Pages 253-258

  Francini, Flavio ^a   Picasso, Mariana ^a   Rebolledo, Oscar R ^a   Salibián, Alfredo ^b   Gagliardino, Juan José ^a  

^a University of La Plata CONICET   (Argentina)

^b Universidad Provincial del Sudoeste   (Argentina)

Author keywords

Alkaline phosphatase; Aspartate aminotransferase; Bufo arenarum; Development; Embryos; Growth; High sugar levels; Larvae; Oviparous model; Glutamyltransferase

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; FRUCTOSE; GALACTOSE; GAMMA GLUTAMYLTRANSFERASE; MANNITOL; SUGAR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY GROWTH; BODY WEIGHT; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; LARVAL DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; TOAD;

EID: 0034233369     PISSN: 07428413     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0742-8413(00)00115-8     Document Type: Article

References (37)

1. Aerts L., Van Assche F.A. Rat foetal endocrine pancreas in experimental diabetes. J. Endocrinol. 73:1977;339-346.
2. Bradford M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
3. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care. 15:1992;1835-1843.
4. Brownlee M., Cerami A. The biochemistry of the complications of diabetes mellitus. Ann. Rev. Biochem. 50:1981;385-407.
5. Brownlee M., Cerami A., Vlassara H. Advanced glycosilation end products in tissue and the biochemical basis of diabetes complications. New Engl. J. Med. 318:1988;1315-1321.
6. Castiñeiras M.J., Boronat A., Itarte E., Guinovart J.J., Rosell-Pérez M. Inducción de diabetes experimental en la rana. Rev. Esp. Fisiol. 34:1978;385-388.
7. Chalmers A.D., Slack J.M.W. Development of the gut in Xenopus laevis. Dev. Dyn. 212:1998;509-521.
8. del Conte E., Sirlin J.L. Pattern series of the first embryonary stages in Bufo arenarum. Anat. Rec. 112(1):1952;125-135.
9. Deuchar E.M. Biochemical Aspects of Amphibian Development. 1966;Methuen, London.
10. Dvornik D. Aldose reductase inhibitors. Porte D. Aldose Reductase Inhibition. An Approach to the Prevention of Diabetes Complications. 1987;222-323 Mc Graw-Hill, New York, NY.
11. Eizirik D.L., Korbutt G.S., Hellerström C. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs B-cell function. J. Clin. Invest. 90:1992;1263-1268.
12. Engerman R.L., Kern T.S. Experimental galactosemia produces diabetic-like retinopathy. Diabetes. 33:1984;97-100.
13. Francini F., Gagliardino J.J. An in vitro model suitable for studying insulin secretion in amphibians. Gen. Comp. Endocrinol. 98:1995;121-128.
14. Francini F., Gagliardino J.J. Effect of carbohydrates upon insulin secretion in vitro in the toad. Comp. Biochem. Physiol. B. 121:1998;111-115.
15. +-channels on insulin secretion in the pancreas of amphibians. Arch. Physiol. Biochem. 105:1997;66-70.
16. Gagliardino J.J., Rebolledo O.R. Glicosilación no enzimática de proteínas y complicaciones crónicas de la diabetes. Rull J.A., Torrilla E., Jadzinsky M.N., Santiago J.V. Diabetes Mellitus: Complicaciones Crónicas. 1992;59-70 Interamericana, McGraw-Hill, México.
17. Giardino I., Edelstein D., Brownlee M. Nonenzymatic glycosilation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. J. Clin. Invest. 94:1994;110-117.
18. Giardino I., Edelstein D., Brownlee M. BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J. Clin. Invest. 97:1996;1422-1428.
19. Gosner K.L. A simplified table for staging anuran embryos and larvae with notes on identification. Herpetologica. 16:1960;183-190.
20. Greene D.A., Lattimer S.A., Sima A.A.F. Sorbitol, phosphoinositides and the sodium-potasium ATPase in the pathogenesis of diabetic complications. New Engl. J. Med. 316:1987;599-606.
21. Hales C.N., Barker D.J.P., Clark P.M.S., Cox L., Fall C.H.D., Osmond C. et al. Fetal and infant growth and impaired glucose tolerance at age 64. Br. Med. J. 303:1991;1019-1022.
22. Hoet, J.J., 1969. Normal and abnormal foetal weight gain. In: Wolstenholme, G.E.W. (Eds.), Foetal Autonomy, Ciba Foundation Symposium. London, Churchill, pp. 186-213.
23. Holemans K., Aerts L., Van Assche F.A. Evidence for an insulin resistance in the adult offspring of pregnant streptozotocin-diabetic rats. Diabetologia. 34:1991;81-85.
24. Kervran A., Guillaume M., Jost A. The endocrine pancreas of the foetus from diabetic pregnant rat. Diabetologia. 15:1978;387-393.
25. Kumar S., Khanna S.S. Effect of glucose administration on the blood sugar and pancreatic isltes of the frog, Rana tigrina. Acta Anat. 94:1976;30-39.
26. Leahy J.L., Bonner-Weir S., Weir G.C. B cell disfunction induced by chronic hyperglycemia. Diabetes Care. 15:1992;442-455.
27. Lum G., Gambino S.R. Serum γ-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas on bone. Clin. Chem. 18:1972;358-362.
28. Martyn C.N., Hales C.N., Barker D.J.P., Jespersen S. Fetal growth and hyperinsulinaemia in adult life. Diabetic Med. 15:1998;688-694.
29. McLeod A.F., Boulton A.J.M., Owens D.R., Van Rooy P., Van Gerven J.M.A., Macrury S., Scarpello J.H.B., Segers O., Heller S.R., Van Der Veen E.A. A multi-centre trial of the aldose reductase inhibitor tolrestat, in patients with symptomatic, peripheral neuropathy. North European Tolrestat study group. Diabetes Metab. 18:1992;14-20.
30. Penttilä I.M., Jokela H.A., Viitala A.J., Heikkinen E., Nummi S., Pystynen P., Saastamoinen J. Activities of aspartate and alanine aminotransferases and alkaline phosphatase in sera of healthy subjects. Scand. J. Clin. Lab. Invest. 35:1975;275-284.
31. Ruderman N., Williamson J., Brownlee M. Hyperglycemia, Diabetes and Vascular Disease. 1992;Oxford University Press, Oxford, NY.
32. The Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology Recommended methods for the determination of four enzymes in blood. Scand. J. Clin. Lab. Invest. 33:1974;291-306.
33. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl. J. Med. 329:1993;977-998.
34. Vague P., Moulin J.P. The defective glucose sensitivity of the B cell in non-insulin-dependent diabetes: improvement after twenty hours normoglycemia. Metabolism. 31:1982;139-142.
35. Van Assche F.A., Aerts L., Holemans K. Metabolic alterations in adulthood after intrauterine development in mothers with mild diabetes. Diabetes. 40:1991;106-108.
36. von Lawzewitsch I. Modificaciones del islote de Langerhans y renales del sapo por exceso de glucosa. Rev. Soc. Argent. Biol. 38:1962;320-330.
37. WHO Study Group, 1985. Diabetes Mellitus. Technical Report Series 727.